BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27409817)

  • 1. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
    Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
    Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
    J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.
    Espinosa-de-Los-Monteros AL; Sosa-Eroza E; Espinosa E; Mendoza V; Arreola R; Mercado M
    Endocr Pract; 2017 Jul; 23(7):759-767. PubMed ID: 28332874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
    Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.
    Stolyarov Y; Mirocha J; Mamelak AN; Ben-Shlomo A
    Pituitary; 2018 Feb; 21(1):41-49. PubMed ID: 29143885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
    Erfe JM; Perry A; McClaskey J; Inzucchi SE; James WS; Eid T; Bronen RA; Mahajan A; Huttner A; Santos F; Spencer D
    J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
    Newell-Price J; Pivonello R; Tabarin A; Fleseriu M; Witek P; Gadelha MR; Petersenn S; Tauchmanova L; Ravichandran S; Gupta P; Lacroix A; Biller BMK
    Eur J Endocrinol; 2020 Feb; 182(2):207-217. PubMed ID: 31804965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosurgical Management of Patients With Persistent or Recurrent Cushing Disease After Prior Transsphenoidal Surgery: A Management Algorithm Based on a 25-Year Experience.
    Hughes JD; Young WF; Chang AY; Link MJ; Garces YI; Laack NN; Thompson GB; Pollock BE
    Neurosurgery; 2020 Apr; 86(4):557-564. PubMed ID: 31140563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
    Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cyclic Cushing's disease using late night salivary cortisol testing.
    Jahandideh D; Swearingen B; Nachtigall LB; Klibanski A; Biller BMK; Tritos NA
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):336-345. PubMed ID: 29873834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
    Dehdashti AR; Gentili F
    Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease.
    Trementino L; Cardinaletti M; Concettoni C; Marcelli G; Polenta B; Spinello M; Boscaro M; Arnaldi G
    Pituitary; 2015 Feb; 18(1):60-7. PubMed ID: 24482099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual presentation of pediatric Cushing disease: recurrent corticotropinoma of the posterior pituitary lobe.
    Azevedo MF; Xekouki P; Keil MF; Lange E; Patronas N; Stratakis CA
    J Pediatr Endocrinol Metab; 2010 Jun; 23(6):607-12. PubMed ID: 20662335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.